[1]赵琳,王建明,王峰,等. 甲钴胺离子导入联合复方樟柳碱颞浅动脉旁注射治疗眼肌麻痹[J].眼科新进展,2015,35(7):643-645.[doi:10.13389/j.cnki.rao.2015.0175]
　ZHAO Lin,WANG Jian-Ming,WANG Feng,et al. Mecobalamin ion transmission combined compound anisodine injection near superficial temporal artery for ophthalmoplegia[J].Recent Advances in Ophthalmology,2015,35(7):643-645.[doi:10.13389/j.cnki.rao.2015.0175]
点击复制

 甲钴胺离子导入联合复方樟柳碱颞浅动脉旁注射治疗眼肌麻痹
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
35卷
期数:
2015年7期
页码:
643-645
栏目:
应用研究
出版日期:
2015-07-05

文章信息/Info

Title:
 Mecobalamin ion transmission combined compound anisodine injection near superficial temporal artery for ophthalmoplegia
作者:
 赵琳; 王建明; 王峰; 周爱意
 710004　陕西省西安市，西安交通大学医学院第二附属医院眼科
Author(s):
 ZHAO Lin ; WANG Jian-Ming; WANG Feng ; ZHOU Ai-Yi
 Department of Ophthalmology , the Second Affiliated Hospital , Medical College of Xi ’ an Jiaotong University ,Xi ’ an 7 10004 . Shaanxi Province , China
关键词:
 ; 眼肌麻痹; 甲钴胺; 复方樟柳碱
Keywords:
 ; ophthalmoplegia ;  mecobalamin ;  compound anisodine
DOI:
10.13389/j.cnki.rao.2015.0175
文献标志码:
A
摘要:
 目的　探讨甲钴胺离子导入联合复方樟柳碱颞浅动脉旁注射治疗眼肌麻痹的临床疗效。方法　回顾性分析７５例眼肌麻痹患者的临床资料，按照治疗方法分为３组。联合用药组３０例，患者患侧颞浅动脉旁注射复方樟柳碱注射液２ｍＬ，同时患眼甲钴胺注射液５００μｇ离子导入，每天１次。甲钴胺组２５例，患眼甲钴胺注射液５００μｇ离子导入，每天１次。复方樟柳碱组２０例，患侧颞浅动脉旁注射复方樟柳碱注射液２ｍＬ，每天１次。以上治疗连续１０ｄ为１疗程，每疗程结束后观察并记录患者的主观症状、眼位偏斜、眼肌运动、复视相及副作用，随访６个月。结果　联合用药组治愈率８０．０％，高于甲钴胺组５２．０％及复方樟柳碱组５０．０％，差异均有统计学意义（均为Ｐ＜０．０５），但联合用药组总有效率（８６．７％）与甲钴胺组（８０．０％）及复方樟柳碱组（８５．０％）比较差异均无统计学意义（χ２＝０．４４２８，Ｐ＝０．５０５８；χ２ ＝０．２７７０，Ｐ＝０．８６７９）。联合用药组治愈时间（２９．５±１２．６）ｄ，较甲钴胺组和复方樟柳碱组分别缩短约１０ｄ和１１ｄ，差异均有统计学意义（均为Ｐ＜０．０５）。甲钴胺组和复方樟柳碱组的治愈率、总有效率和治愈时间之间差异均无统计学意义（均为Ｐ＞０．０５）。治疗中无注射部位硬结、出血等发生。结论　甲钴胺离子导入联合复方樟柳碱颞浅动脉旁注射，可提高眼肌麻痹患者治愈率，缩短治疗时间，安全有效，而副作用没有增加。
Abstract:
 Objective To discuss the clinical effects of mecobalamin ion transmission combined compound anisodine injection near superficial temporal artery in the treatment of ophthalmoplegia. Methods Clinical data of 75 patients with ophthalmoplegia were analyzed retrospectively. All patients were divided into three groups. Patients in combined group ( n = 30) were adnunistrated with 2 mL compound anisodine injection near superficial temporal artery plus 500 pdg mecobalamin ion transmission. Patients in mecobalamin group ( n = 25 ) and compound arusodine group ( n = 20 ) were administered with 500 yg mecobalanun by ion transmission and 2 mL compound anisodine by near superficial temporal artery respectively. Each case received the treatment once a day and a treatment course was 10 continuous days. Symptoms, eye position deviation. muscle movement and diplopia were monitored in the end of treatment course and the side effects in general or locally also observed. Results The cure rate in combined group was 80. 0% .which was higher than that in both mecobalamin group ( 52. 0% ) and compound anisodine group (50. 0% ) ( all P < 0. 05 ) .but the total efficiency difference was not significant among three combined group ( 86. 7% ) , mecobalamin group (80. 0% ) and compound anisodine group (85. 0% ) (X2 = 0. 442 8,P = 0. 505 8;X2 = 0. 277 0 ,P = 0. 867 9 ) . The mean duration of cured time in combined group was ( 29. 5 + 12.6) days,which was shorter than those in both mecobalamin group and compound anisodine group about 10 days and 11 days, respectively ( all P < 0. 05 ) . There were no differences of cured rate , efficiency and treatment duration between mecobalamin group and compound anisodine group ( all P > 0. 05 ) . There was no local induration , injection site bleeding , and no worsen original disease observed in all three groups. Conclusion Mecobalanun ion transmission combined compound anisodine injection near superficial temporal artery is effective and safe in treatment of ophthalmoplegia, can rrnprove cured rate , shorten therapeutic time , but don ’ t increase the side effects.

相似文献/References:

[1]刘平 苏胜. 白内障蛋白质组学研究的现状及未来研究方向[J].眼科新进展,2014,34(1):001.
[2]杨宝娣 宋艳萍 陈中山 丁琴. 微脉冲半导体激光对兔视网膜色素上皮细胞阈值下光凝的光生物调制效应[J].眼科新进展,2014,34(1):005.
[3]赖伟霞 梁皓 谭少健 李霞 邹文进 蒋林志. 钙调素在正常人及不同年龄白内障患者晶状体上皮细胞中的表达[J].眼科新进展,2014,34(1):010.
[4]郑燕林 刘聪慧 沙菽. 水蛭提取液对体外培养RF/6A的细胞液中MMP-2、IV型胶原含量的影响[J].眼科新进展,2014,34(1):013.
[5]周琨 高晓唯 蔡岩 李文静 胡裕坤 田丽丽 付燕. CCR7基因修饰的未成熟树突状细胞在大鼠高危角膜移植免疫排斥反应中的作用[J].眼科新进展,2014,34(1):017.
[6]高伟 程燕 吴洁 王亮 赵帅. 肉毒杆菌B诱导大鼠干眼模型中泪腺Lacritin蛋白表达的研究[J].眼科新进展,2014,34(1):021.
[7]赵宁 张瑞君 刘磊 李佳 刘宁宁. PTEN基因对兔晶状体上皮细胞增殖抑制作用的实验研究[J].眼科新进展,2014,34(1):025.
[8]陈雪 李海平 张培 曹安民. 小胶质细胞在视网膜母细胞瘤中的活化及分布研究[J].眼科新进展,2014,34(1):029.
[9]李琴 谢婷玉 陈雪艺 王清 郭乔茜 具尔提·哈第尔. 臭氧灌肠改善糖尿病大鼠的视网膜电图表现[J].眼科新进展,2014,34(1):034.
[10]蔡晶晶 孟倩丽 郭海科 张良 李东风 崔颖. 血红素加氧酶-1在糖尿病视网膜病变患者外周血单个核细胞中的表达[J].眼科新进展,2014,34(1):037.

备注/Memo

备注/Memo:
 陕西省科学技术发展研究项目（编号：２０１２Ｋ１９-０５-０５）
更新日期/Last Update: 2015-07-03